Alaunos Therapeutics (TCRT) Assets (2009 - 2026)
Alaunos Therapeutics' (TCRT) quarterly Assets came in at $1.9 million in Q1 2026, down 11.18% YoY from $2.1 million in Q1 2025, and down 36.51% on a QoQ basis from $3.0 million in Q4 2025.
Alaunos Therapeutics (TCRT) Assets (2009 - 2026) Analysis & Trends
Alaunos Therapeutics (TCRT) has 18 years of Assets data on file, last reported at $1.9 million in Q1 2026.
- Quarterly Assets fell 11.18% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (down 11.18% YoY) and the FY2025 annual result came in at $3.0 million, up 7.66% from the prior year.
- Assets fell to $1.9 million in Q1 2026, from $3.0 million in the prior quarter.
- In the past five years, Assets ranged from a high of $85.0 million in Q1 2022 to a low of $1.9 million in Q1 2026.
- A 5-year average of $25.2 million and a median of $6.0 million in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets tumbled 87.59% — and 2025, when it advanced 7.66%.
- Tracing TCRT's Assets over 5 years: stood at $64.9 million in 2022, then plunged by 87.28% to $8.3 million in 2023, then slumped by 66.66% to $2.8 million in 2024, then climbed by 7.66% to $3.0 million in 2025, then sank by 36.51% to $1.9 million in 2026.
- The last three Assets figures came in at $1.9 million (Q1 2026), $3.0 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - | 1.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.88 Mn |
| Dec 31, 2025 | 2.97 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Jun 30, 2025 | 4.74 Mn |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 2.76 Mn |
| Sep 30, 2024 | 3.55 Mn |
| Jun 30, 2024 | 4.68 Mn |
| Mar 31, 2024 | 6.04 Mn |
| Dec 31, 2023 | 8.26 Mn |
| Sep 30, 2023 | 19.44 Mn |
| Jun 30, 2023 | 27.93 Mn |
| Mar 31, 2023 | 48.64 Mn |
| Dec 31, 2022 | 64.94 Mn |
| Sep 30, 2022 | 67.34 Mn |
| Jun 30, 2022 | 73.93 Mn |
| Mar 31, 2022 | 84.99 Mn |
| Dec 31, 2021 | 94.87 Mn |
| Sep 30, 2021 | 113.76 Mn |
| Jun 30, 2021 | 106.77 Mn |